Form 4 for URGN UroGen Pharma Ltd.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-26 · accession 0001437749-26-006124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-27 | 2025-02-26 | URGN | Robinson James A. Jr. | Dir | M - OptEx | — | +2,000 | 4,000 | +100% | — |
| D | 2026-02-27 | 2025-02-26 | URGN | Robinson James A. Jr. | Dir | M - OptEx | $0.00 | -2,000 | 4,000 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ordinary shares | 2025-02-26 | M | A | 2,000 | — | 4,000 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer |
| 2 | Derivative | Restricted Stock Unit | 2025-02-26 | M | D | 2,000 | $0.00 | 4,000 | D | — · — to — | 2,000 Ordinary Shares | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer |